{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:40:31Z","timestamp":1787848831709,"version":"build-2784847793"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T00:00:00Z","timestamp":1376438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,8,14]],"date-time":"2013-08-14T00:00:00Z","timestamp":1376438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s13365-013-0192-8","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T15:46:53Z","timestamp":1376408813000},"page":"164-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy\/tropical spastic paraparesis"],"prefix":"10.1007","volume":"20","author":[{"given":"Mineki","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,14]]},"reference":[{"key":"192_CR1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/13550280601039634","volume":"12","author":"V Adaui","year":"2006","unstructured":"Adaui V, Verdonck K, Best I, Gonzalez E, Tipismana M, Arevalo J, Vanham G, Campos M, Zimic M, Gotuzzo E (2006) SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness. J Neurovirol 12:456\u2013465","journal-title":"J Neurovirol"},{"key":"192_CR2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.1993.tb05973.x","volume":"94","author":"A Ali","year":"1993","unstructured":"Ali A, Patterson S, Cruickshank K, Rudge P, Dalgleish AG, Knight SC (1993) Dendritic cells infected in vitro with human T cell leukaemia\/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis. Clin Exp Immunol 94:32\u201337","journal-title":"Clin Exp Immunol"},{"key":"192_CR3","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S1474-4422(06)70628-7","volume":"5","author":"AQ Araujo","year":"2006","unstructured":"Araujo AQ, Silva MT (2006) The HTLV-1 neurological complex. Lancet Neurol 5:1068\u20131076","journal-title":"Lancet Neurol"},{"key":"192_CR4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s004019900170","volume":"100","author":"MM Aye","year":"2000","unstructured":"Aye MM, Matsuoka E, Moritoyo T, Umehara F, Suehara M, Hokezu Y, Yamanaka H, Isashiki Y, Osame M, Izumo S (2000) Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy\/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol 100:245\u2013252","journal-title":"Acta Neuropathol"},{"issue":"15","key":"192_CR5","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1182\/blood-2009-02-203042","volume":"114","author":"K Azakami","year":"2009","unstructured":"Azakami K, Sato T, Araya N, Utsunomiya A, Kubota R, Suzuki K, Hasegawa D, Izumi T, Fujita H, Aratani S, Fujii R, Yagishita N, Kamijuku H, Kanekura T, Seino KI, Nishioka K, Nakajima T, Yamano Y (2009) Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders. Blood 114(15):3208\u20133215. doi:10.1182\/blood-2009-02-203042","journal-title":"Blood"},{"key":"192_CR6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0952-7915(00)00107-2","volume":"12","author":"CR Bangham","year":"2000","unstructured":"Bangham CR (2000) The immune response to HTLV-I. Curr Opin Immunol 12:397\u2013402","journal-title":"Curr Opin Immunol"},{"key":"192_CR7","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1038\/sj.onc.1208970","volume":"24","author":"CR Bangham","year":"2005","unstructured":"Bangham CR, Osame M (2005) Cellular immune response to HTLV-1. Oncogene 24:6035\u20136046","journal-title":"Oncogene"},{"key":"192_CR8","doi-asserted-by":"crossref","first-page":"e777","DOI":"10.1111\/j.1365-2567.2009.03082.x","volume":"128","author":"I Best","year":"2009","unstructured":"Best I, Lopez G, Verdonck K, Gonzalez E, Tipismana M, Gotuzzo E, Vanham G, Clark D (2009) IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM\/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population. Immunology 128:e777\u2013e786","journal-title":"Immunology"},{"key":"192_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mus.880160106","volume":"16","author":"AI Bhigjee","year":"1993","unstructured":"Bhigjee AI, Bill PL, Wiley CA, Windsor IM, Matthias DA, Amenomori T, Wachsman W, Moorhouse D (1993) Peripheral nerve lesions in HTLV-I associated myelopathy (HAM\/TSP). Muscle Nerve 16:21\u201326","journal-title":"Muscle Nerve"},{"key":"192_CR10","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/blood-2012-07-445593","volume":"120","author":"LB Cook","year":"2012","unstructured":"Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CR (2012) HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood 120:3488\u20133490","journal-title":"Blood"},{"key":"192_CR11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/aid.1993.9.381","volume":"9","author":"G de The","year":"1993","unstructured":"de The G, Bomford R (1993) An HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retrovir 9:381\u2013386","journal-title":"AIDS Res Hum Retrovir"},{"key":"192_CR12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-4690-9-16","volume":"9","author":"Y Enose-Akahata","year":"2012","unstructured":"Enose-Akahata Y, Matsuura E, Tanaka Y, Oh U, Jacobson S (2012) Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease. Retrovirology 9:16","journal-title":"Retrovirology"},{"key":"192_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-4690-10-19","volume":"10","author":"Y Enose-Akahata","year":"2013","unstructured":"Enose-Akahata Y, Abrams A, Massoud R, Bialuk I, Johnson KR, Green PL, Maloney EM, Jacobson S (2013) Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals. Retrovirology 10:19","journal-title":"Retrovirology"},{"key":"192_CR14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1086\/315897","volume":"182","author":"Y Furukawa","year":"2000","unstructured":"Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M (2000) Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Infect Dis 182:1343\u20131349","journal-title":"J Infect Dis"},{"key":"192_CR15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407\u2013410","journal-title":"Lancet"},{"key":"192_CR16","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1182\/blood-2010-10-312926","volume":"117","author":"NA Gillet","year":"2011","unstructured":"Gillet NA, Malani N, Melamed A, Gormley N, Carter R, Bentley D, Berry C, Bushman FD, Taylor GP, Bangham CR (2011) The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 117:3113\u20133122","journal-title":"Blood"},{"key":"192_CR17","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood.V99.9.3335","volume":"99","author":"PK Goon","year":"2002","unstructured":"Goon PK, Hanon E, Igakura T, Tanaka Y, Weber JN, Taylor GP, Bangham CR (2002) High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis. Blood 99:3335\u20133341","journal-title":"Blood"},{"key":"192_CR18","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.1128\/JVI.77.17.9716-9722.2003","volume":"77","author":"PK Goon","year":"2003","unstructured":"Goon PK, Igakura T, Hanon E, Mosley AJ, Asquith B, Gould KG, Taylor GP, Weber JN, Bangham CR (2003) High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease. J Virol 77:9716\u20139722","journal-title":"J Virol"},{"key":"192_CR19","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1086\/420832","volume":"189","author":"PK Goon","year":"2004","unstructured":"Goon PK, Biancardi A, Fast N, Igakura T, Hanon E, Mosley AJ, Asquith B, Gould KG, Marshall S, Taylor GP, Bangham CR (2004a) Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy. J Infect Dis 189:2294\u20132298","journal-title":"J Infect Dis"},{"key":"192_CR20","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4049\/jimmunol.172.3.1735","volume":"172","author":"PK Goon","year":"2004","unstructured":"Goon PK, Igakura T, Hanon E, Mosley AJ, Barfield A, Barnard AL, Kaftantzi L, Tanaka Y, Taylor GP, Weber JN, Bangham CR (2004b) Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I. J Immunol 172:1735\u20131743","journal-title":"J Immunol"},{"key":"192_CR21","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1073\/pnas.95.13.7568","volume":"95","author":"TF Greten","year":"1998","unstructured":"Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, Pardoll DM, Jacobson S, Schneck JP (1998) Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM\/TSP patients. Proc Natl Acad Sci U S A 95:7568\u20137573","journal-title":"Proc Natl Acad Sci U S A"},{"key":"192_CR22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ijc.2910600423","volume":"60","author":"E Hakoda","year":"1995","unstructured":"Hakoda E, Machida H, Tanaka Y, Morishita N, Sawada T, Shida H, Hoshino H, Miyoshi I (1995) Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I. Int J Cancer 60:567\u2013570","journal-title":"Int J Cancer"},{"key":"192_CR23","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood.V95.4.1386.004k22_1386_1392","volume":"95","author":"E Hanon","year":"2000","unstructured":"Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, Usuku K, Osame M, Weber JN, Bangham CR (2000) Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95:1386\u20131392","journal-title":"Blood"},{"key":"192_CR24","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/aid.1991.7.1031","volume":"7","author":"WJ Harrington Jr","year":"1991","unstructured":"Harrington WJ Jr, Sheremata WA, Snodgrass SR, Emerson S, Phillips S, Berger JR (1991) Tropical spastic paraparesis\/HTLV-1-associated myelopathy (TSP\/HAM): treatment with an anabolic steroid danazol. AIDS Res Hum Retrovir 7:1031\u20131034","journal-title":"AIDS Res Hum Retrovir"},{"issue":"5","key":"192_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/13550280802178538","volume":"14","author":"D Hayashi","year":"2008","unstructured":"Hayashi D, Kubota R, Takenouchi N, Nakamura T, Umehara F, Arimura K, Izumo S, Osame M (2008a) Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy. J Neurovirol 14(5):459\u2013463. doi:10.1080\/13550280802178538","journal-title":"J Neurovirol"},{"key":"192_CR26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jneuroim.2008.06.005","volume":"200","author":"D Hayashi","year":"2008","unstructured":"Hayashi D, Kubota R, Takenouchi N, Tanaka Y, Hirano R, Takashima H, Osame M, Izumo S, Arimura K (2008b) Reduced Foxp3 expression with increased cytomegalovirus-specific CTL in HTLV-I-associated myelopathy. J Neuroimmunol 200:115\u2013124","journal-title":"J Neuroimmunol"},{"key":"192_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/mus.880150108","volume":"15","author":"I Higuchi","year":"1992","unstructured":"Higuchi I, Nerenberg M, Yoshimine K, Yoshida M, Fukunaga H, Tajima K, Osame M (1992) Failure to detect HTLV-I by in situ hybridization in the biopsied muscles of viral carriers with polymyositis. Muscle Nerve 15:43\u201347","journal-title":"Muscle Nerve"},{"key":"192_CR28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/infdis\/jiq078","volume":"203","author":"S Hilburn","year":"2011","unstructured":"Hilburn S, Rowan A, Demontis MA, MacNamara A, Asquith B, Bangham CR, Taylor GP (2011) In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. J Infect Dis 203:529\u2013536","journal-title":"J Infect Dis"},{"key":"192_CR29","first-page":"474","volume":"76","author":"S Hino","year":"1985","unstructured":"Hino S, Yamaguchi K, Katamine S, Sugiyama H, Amagasaki T, Kinoshita K, Yoshida Y, Doi H, Tsuji Y, Miyamoto T (1985) Mother-to-child transmission of human T-cell leukemia virus type-I. Jpn J Cancer Res 76:474\u2013480","journal-title":"Jpn J Cancer Res"},{"key":"192_CR30","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, Shirakawa S, Miyoshi I (1981) Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A 78:6476\u20136480","journal-title":"Proc Natl Acad Sci U S A"},{"key":"192_CR31","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1086\/424598","volume":"190","author":"M Hisada","year":"2004","unstructured":"Hisada M, Stuver SO, Okayama A, Li HC, Sawada T, Hanchard B, Mueller NE (2004) Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers. J Infect Dis 190:1605\u20131609","journal-title":"J Infect Dis"},{"key":"192_CR32","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199304223281608","volume":"328","author":"P Hollsberg","year":"1993","unstructured":"Hollsberg P, Hafler DA (1993) Seminars in medicine of the Beth Israel Hospital, Boston. Pathogenesis of diseases induced by human lymphotropic virus type I infection. N Engl J Med 328:1173\u20131182","journal-title":"N Engl J Med"},{"key":"192_CR33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0165-5728(89)90037-4","volume":"23","author":"S Ijichi","year":"1989","unstructured":"Ijichi S, Eiraku N, Osame M, Izumo S, Kubota R, Maruyama I, Matsumoto M, Sonoda S (1989) In vitro modulation of lymphocyte proliferation by prednisolone and interferon-alpha in patients with HTLV-I-associated myelopathy (HAM). J Neuroimmunol 23:175\u2013178","journal-title":"J Neuroimmunol"},{"key":"192_CR34","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/j.1460-2075.1986.tb04583.x","volume":"5","author":"J Inoue","year":"1986","unstructured":"Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M (1986) Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J 5:2883\u20132888","journal-title":"EMBO J"},{"key":"192_CR35","first-page":"199","volume":"7","author":"S Ishihara","year":"1994","unstructured":"Ishihara S, Okayama A, Stuver S, Horinouchi H, Shioiri S, Murai K, Kubota T, Yamashita R, Tachibana N, Tsubouchi H et al (1994) Association of HTLV-I antibody profile of asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells. J Acquir Immune Defic Syndr 7:199\u2013203","journal-title":"J Acquir Immune Defic Syndr"},{"key":"192_CR36","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.38.8.1302","volume":"38","author":"Y Itoyama","year":"1988","unstructured":"Itoyama Y, Minato S, Kira J, Goto I, Sato H, Okochi K, Yamamoto N (1988) Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy. Neurology 38:1302\u20131307","journal-title":"Neurology"},{"key":"192_CR37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0022-510X(90)90060-Z","volume":"96","author":"Y Iwasaki","year":"1990","unstructured":"Iwasaki Y (1990) Pathology of chronic myelopathy associated with HTLV-I infection (HAM\/TSP). J Neurol Sci 96:103\u2013123","journal-title":"J Neurol Sci"},{"key":"192_CR38","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","volume":"46","author":"S Izumo","year":"1996","unstructured":"Izumo S, Goto I, Itoyama Y, Okajima T, Watanabe S, Kuroda Y, Araki S, Mori M, Nagataki S, Matsukura S, Akamine T, Nakagawa M, Yamamoto I, Osame M (1996) Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology 46:1016\u20131021","journal-title":"Neurology"},{"issue":"Suppl","key":"192_CR39","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1046\/j.1440-1789.2000.00320.x","volume":"20","author":"S Izumo","year":"2000","unstructured":"Izumo S, Umehara F, Osame M (2000) HTLV-I-associated myelopathy. Neuropathology 20(Suppl):S65\u2013S68","journal-title":"Neuropathology"},{"issue":"Suppl 2","key":"192_CR40","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1086\/344269","volume":"186","author":"S Jacobson","year":"2002","unstructured":"Jacobson S (2002) Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J Infect Dis 186(Suppl 2):S187\u2013S192","journal-title":"J Infect Dis"},{"key":"192_CR41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/348245a0","volume":"348","author":"S Jacobson","year":"1990","unstructured":"Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S (1990) Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348:245\u2013248","journal-title":"Nature"},{"key":"192_CR42","doi-asserted-by":"crossref","first-page":"10908","DOI":"10.1128\/JVI.01054-09","volume":"83","author":"P Jain","year":"2009","unstructured":"Jain P, Manuel SL, Khan ZK, Ahuja J, Quann K, Wigdahl B (2009) DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells. J Virol 83:10908\u201310921","journal-title":"J Virol"},{"key":"192_CR43","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","volume":"96","author":"KJ Jeffery","year":"1999","unstructured":"Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, Lloyd AL, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M, Bangham CR (1999) HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 96:3848\u20133853","journal-title":"Proc Natl Acad Sci U S A"},{"key":"192_CR44","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.4049\/jimmunol.165.12.7278","volume":"165","author":"KJ Jeffery","year":"2000","unstructured":"Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD, Izumo S, Usuku K, Welsh KI, Osame M, Bangham CR (2000) The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 165:7278\u20137284","journal-title":"J Immunol"},{"key":"192_CR45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm1745","volume":"14","author":"KS Jones","year":"2008","unstructured":"Jones KS, Petrow-Sadowski C, Huang YK, Bertolette DC, Ruscetti FW (2008) Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat Med 14:429\u2013436","journal-title":"Nat Med"},{"key":"192_CR46","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/intimm\/3.8.761","volume":"3","author":"M Kannagi","year":"1991","unstructured":"Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, Kuwashima G, Sato S, Morita M, Kidokoro M, Sugimoto M et al (1991) Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int Immunol 3:761\u2013767","journal-title":"Int Immunol"},{"key":"192_CR47","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.4049\/jimmunol.0900069","volume":"182","author":"T Kattan","year":"2009","unstructured":"Kattan T, MacNamara A, Rowan AG, Nose H, Mosley AJ, Tanaka Y, Taylor GP, Asquith B, Bangham CR (2009) The avidity and lytic efficiency of the CTL response to HTLV-1. J Immunol 182:5723\u20135729","journal-title":"J Immunol"},{"key":"192_CR48","first-page":"674","volume":"78","author":"K Kinoshita","year":"1987","unstructured":"Kinoshita K, Amagasaki T, Hino S, Doi H, Yamanouchi K, Ban N, Momita S, Ikeda S, Kamihira S, Ichimaru M et al (1987) Milk-borne transmission of HTLV-I from carrier mothers to their children. Jpn J Cancer Res 78:674\u2013680","journal-title":"Jpn J Cancer Res"},{"key":"192_CR49","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1128\/JVI.02564-08","volume":"83","author":"S Kinpara","year":"2009","unstructured":"Kinpara S, Hasegawa A, Utsunomiya A, Nishitsuji H, Furukawa H, Masuda T, Kannagi M (2009) Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon. J Virol 83:5101\u20135108","journal-title":"J Virol"},{"key":"192_CR50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0022-510X(92)90215-7","volume":"107","author":"J Kira","year":"1992","unstructured":"Kira J, Nakamura M, Sawada T, Koyanagi Y, Ohori N, Itoyama Y, Yamamoto N, Sakaki Y, Goto I (1992) Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy\/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load. J Neurol Sci 107:98\u2013104","journal-title":"J Neurol Sci"},{"key":"192_CR51","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2249.1998.00497.x","volume":"111","author":"B Kitze","year":"1998","unstructured":"Kitze B, Usuku K, Yamano Y, Yashiki S, Nakamura M, Fujiyoshi T, Izumo S, Osame M, Sonoda S (1998) Human CD4+ T lymphocytes recognize a highly conserved epitope of human T lymphotropic virus type 1 (HTLV-1) env gp21 restricted by HLA DRB1*0101. Clin Exp Immunol 111:278\u2013285","journal-title":"Clin Exp Immunol"},{"key":"192_CR52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-510X(02)00279-4","volume":"206","author":"T Kiwaki","year":"2003","unstructured":"Kiwaki T, Umehara F, Arimura Y, Izumo S, Arimura K, Itoh K, Osame M (2003) The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy. J Neurol Sci 206:17\u201321","journal-title":"J Neurol Sci"},{"key":"192_CR53","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1073\/pnas.81.19.6202","volume":"81","author":"T Kiyokawa","year":"1984","unstructured":"Kiyokawa T, Yoshikura H, Hattori S, Seiki M, Yoshida M (1984) Envelope proteins of human T-cell leukemia virus: expression in Escherichia coli and its application to studies of env gene functions. Proc Natl Acad Sci U S A 81:6202\u20136206","journal-title":"Proc Natl Acad Sci U S A"},{"key":"192_CR54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1997.tb01003.x","volume":"159","author":"P Klenerman","year":"1997","unstructured":"Klenerman P, Zinkernagel RM (1997) What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus? Immunol Rev 159:5\u201316","journal-title":"Immunol Rev"},{"key":"192_CR55","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jneuroim.2004.07.007","volume":"156","author":"D Kodama","year":"2004","unstructured":"Kodama D, Saito M, Matsumoto W, Sabouri AH, Izumo S, Arimura K, Usuku K, Bangham CR, Osame M (2004) Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). J Neuroimmunol 156:188\u2013194","journal-title":"J Neuroimmunol"},{"key":"192_CR56","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/oxfordjournals.aje.a117580","volume":"142","author":"A Kramer","year":"1995","unstructured":"Kramer A, Maloney EM, Morgan OS, Rodgers-Johnson P, Manns A, Murphy EL, Larsen S, Cranston B, Murphy J, Benichou J et al (1995) Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica. Am J Epidemiol 142:1212\u20131220","journal-title":"Am J Epidemiol"},{"key":"192_CR57","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4049\/jimmunol.161.1.482","volume":"161","author":"R Kubota","year":"1998","unstructured":"Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S (1998) Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy\/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol 161:482\u2013488","journal-title":"J Immunol"},{"key":"192_CR58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00315327","volume":"238","author":"Y Kuroda","year":"1991","unstructured":"Kuroda Y, Takashima H, Ikeda A, Endo C, Neshige R, Kakigi R, Shibasaki H (1991) Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin. J Neurol 238:309\u2013314","journal-title":"J Neurol"},{"key":"192_CR59","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(90)92896-P","volume":"336","author":"L LaGrenade","year":"1990","unstructured":"LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W (1990) Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 336:1345\u20131347","journal-title":"Lancet"},{"key":"192_CR60","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/infdis\/169.3.496","volume":"169","author":"RB Lal","year":"1994","unstructured":"Lal RB, Giam CZ, Coligan JE, Rudolph DL (1994) Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy. J Infect Dis 169:496\u2013503","journal-title":"J Infect Dis"},{"key":"192_CR61","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coi.2010.11.003","volume":"23","author":"SY Liu","year":"2011","unstructured":"Liu SY, Sanchez DJ, Cheng G (2011) New developments in the induction and antiviral effectors of type I interferon. Curr Opin Immunol 23:57\u201364","journal-title":"Curr Opin Immunol"},{"key":"192_CR62","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1089\/aid.1992.8.1699","volume":"8","author":"SE Macatonia","year":"1992","unstructured":"Macatonia SE, Cruickshank JK, Rudge P, Knight SC (1992) Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res Hum Retrovir 8:1699\u20131706","journal-title":"AIDS Res Hum Retrovir"},{"key":"192_CR63","doi-asserted-by":"crossref","unstructured":"Macnamara A, Rowan A, Hilburn S, Kadolsky U, Fujiwara H, Suemori K, Yasukawa M, Taylor G, Bangham CR, Asquith B (2010) HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog 6","DOI":"10.1371\/journal.ppat.1001117"},{"key":"192_CR64","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/CDLI.6.3.316-322.1999","volume":"6","author":"M Makino","year":"1999","unstructured":"Makino M, Azuma M, Wakamatsu SI, Suruga Y, Izumo S, Yokoyama MM, Baba M (1999) Marked suppression of T cells by a benzothiophene derivative in patients with human T-lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis. Clin Diagn Lab Immunol 6:316\u2013322","journal-title":"Clin Diagn Lab Immunol"},{"key":"192_CR65","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/315088","volume":"180","author":"A Manns","year":"1999","unstructured":"Manns A, Miley WJ, Wilks RJ, Morgan OS, Hanchard B, Wharfe G, Cranston B, Maloney E, Welles SL, Blattner WA, Waters D (1999) Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. J Infect Dis 180:1487\u20131493","journal-title":"J Infect Dis"},{"key":"192_CR66","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1189\/jlb.0309172","volume":"86","author":"SL Manuel","year":"2009","unstructured":"Manuel SL, Schell TD, Acheampong E, Rahman S, Khan ZK, Jain P (2009) Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease. J Leukoc Biol 86:1205\u20131216","journal-title":"J Leukoc Biol"},{"key":"192_CR67","doi-asserted-by":"crossref","first-page":"e1675","DOI":"10.1371\/journal.pntd.0001675","volume":"6","author":"F Martin","year":"2012","unstructured":"Martin F, Castro H, Gabriel C, Adonis A, Fedina A, Harrison L, Brodnicki L, Demontis MA, Babiker AG, Weber JN, Bangham CR, Taylor GP (2012) Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy\/tropical spastic paraparesis. PLoS Negl Trop Dis 6:e1675","journal-title":"PLoS Negl Trop Dis"},{"key":"192_CR68","first-page":"46","volume":"137","author":"I Maruyama","year":"1988","unstructured":"Maruyama I, Chihara J, Sakashita I, Mizoguchi R, Mori S, Usuku K, Jonosono M, Tara M, Matsumoto M, Niina S, Sonoda S, Yasaki S, Osame M (1988) HTLV-I associated bronchopneumonopathy\u2014a new clinical entity? Am Rev Resp Dis 137:46","journal-title":"Am Rev Resp Dis"},{"key":"192_CR69","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(88)90525-9","volume":"2","author":"H Matsuo","year":"1988","unstructured":"Matsuo H, Nakamura T, Tsujihata M, Kinoshita I, Satoh A, Tomita I, Shirabe S, Shibayama K, Nagataki S (1988) Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy. Lancet 2:1109\u20131113","journal-title":"Lancet"},{"key":"192_CR70","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/onc.2010.537","volume":"30","author":"M Matsuoka","year":"2011","unstructured":"Matsuoka M, Jeang KT (2011) Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene 30:1379\u20131389","journal-title":"Oncogene"},{"key":"192_CR71","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11481-010-9216-9","volume":"5","author":"E Matsuura","year":"2010","unstructured":"Matsuura E, Yamano Y, Jacobson S (2010) Neuroimmunity of HTLV-I infection. J Neuroimmune Pharmacol 5:310\u2013325","journal-title":"J Neuroimmune Pharmacol"},{"key":"192_CR72","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2005.05.011","volume":"237","author":"T Matsuzaki","year":"2005","unstructured":"Matsuzaki T, Saito M, Usuku K, Nose H, Izumo S, Arimura K, Osame M (2005) A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy\/tropical spastic paraparesis. J Neurol Sci 237:75\u201381","journal-title":"J Neurol Sci"},{"key":"192_CR73","doi-asserted-by":"crossref","first-page":"e1003271","DOI":"10.1371\/journal.ppat.1003271","volume":"9","author":"A Melamed","year":"2013","unstructured":"Melamed A, Laydon DJ, Gillet NA, Tanaka Y, Taylor GP, Bangham CR (2013) Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog 9:e1003271","journal-title":"PLoS Pathog"},{"key":"192_CR74","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/294770a0","volume":"294","author":"I Miyoshi","year":"1981","unstructured":"Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y (1981) Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294:770\u2013771","journal-title":"Nature"},{"key":"192_CR75","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0140-6736(92)90699-4","volume":"339","author":"M Mochizuki","year":"1992","unstructured":"Mochizuki M, Yamaguchi K, Takatsuki K, Watanabe T, Mori S, Tajima K (1992) HTLV-I and uveitis. Lancet 339:1110","journal-title":"Lancet"},{"key":"192_CR76","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(89)91793-5","volume":"2","author":"OS Morgan","year":"1989","unstructured":"Morgan OS, Rodgers-Johnson P, Mora C, Char G (1989) HTLV-1 and polymyositis in Jamaica. Lancet 2:1184\u20131187","journal-title":"Lancet"},{"key":"192_CR77","first-page":"1971","volume":"10","author":"N Murata","year":"1996","unstructured":"Murata N, Hakoda E, Machida H, Ikezoe T, Sawada T, Hoshino H, Miyoshi I (1996) Prevention of human T cell lymphotropic virus type I infection in Japanese macaques by passive immunization. Leukemia 10:1971\u20131974","journal-title":"Leukemia"},{"key":"192_CR78","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S, Osame M (1998) Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol 4:586\u2013593","journal-title":"J Neurovirol"},{"key":"192_CR79","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/317932","volume":"183","author":"M Nagai","year":"2001","unstructured":"Nagai M, Kubota R, Greten TF, Schneck JP, Leist TP, Jacobson S (2001a) Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis: correlation with HTLV-I provirus load. J Infect Dis 183:197\u2013205","journal-title":"J Infect Dis"},{"key":"192_CR80","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.10065","volume":"50","author":"M Nagai","year":"2001","unstructured":"Nagai M, Yamano Y, Brennan MB, Mora CA, Jacobson S (2001b) Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM\/TSP. Ann Neurol 50:807\u2013812","journal-title":"Ann Neurol"},{"key":"192_CR81","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-510X(91)90165-4","volume":"103","author":"K Nagasato","year":"1991","unstructured":"Nagasato K, Nakamura T, Shirabe S, Shibayama K, Ohishi K, Ichinose K, Tsujihata M, Nagataki S (1991) Presence of serum anti-human T-lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I-associated myelopathy. J Neurol Sci 103:203\u2013208","journal-title":"J Neurol Sci"},{"key":"192_CR82","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/13550289509111010","volume":"1","author":"M Nakagawa","year":"1995","unstructured":"Nakagawa M, Izumo S, Ijichi S, Kubota H, Arimura K, Kawabata M, Osame M (1995) HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1:50\u201361","journal-title":"J Neurovirol"},{"key":"192_CR83","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/13550289609146899","volume":"2","author":"M Nakagawa","year":"1996","unstructured":"Nakagawa M, Nakahara K, Maruyama Y, Kawabata M, Higuchi I, Kubota H, Izumo S, Arimura K, Osame M (1996) Therapeutic trials in 200 patients with HTLV-I-associated myelopathy\/ tropical spastic paraparesis. J Neurovirol 2:345\u2013355","journal-title":"J Neurovirol"},{"key":"192_CR84","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.2910400320","volume":"40","author":"H Nakamura","year":"1987","unstructured":"Nakamura H, Hayami M, Ohta Y, Ishikawa K, Tsujimoto H, Kiyokawa T, Yoshida M, Sasagawa A, Honjo S (1987) Protection of cynomolgus monkeys against infection by human T-cell leukemia virus type-I by immunization with viral env gene products produced in Escherichia coli. Int J Cancer 40:403\u2013407","journal-title":"Int J Cancer"},{"key":"192_CR85","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood-2010-03-272690","volume":"117","author":"CR Nascimento","year":"2011","unstructured":"Nascimento CR, Lima MA, de Andrada Serpa MJ, Espindola O, Leite AC, Echevarria-Lima J (2011) Monocytes from HTLV-1-infected patients are unable to fully mature into dendritic cells. Blood 117:489\u2013499","journal-title":"Blood"},{"issue":"3","key":"192_CR86","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/j.1365-2249.2009.04019.x","volume":"158","author":"LC Ndhlovu","year":"2009","unstructured":"Ndhlovu LC, Snyder-Cappione JE, Carvalho KI, Leal FE, Loo CP, Bruno FR, Jha AR, Devita D, Hasenkrug AM, Barbosa HM, Segurado AC, Nixon DF, Murphy EL, Kallas EG (2009) Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease. Clin Exp Immunol 158(3):294\u2013299. doi:10.1111\/j.1365-2249.2009.04019.x","journal-title":"Clin Exp Immunol"},{"key":"192_CR87","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0140-6736(89)90038-X","volume":"1","author":"K Nishioka","year":"1989","unstructured":"Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M (1989) Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1:441","journal-title":"Lancet"},{"key":"192_CR88","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1086\/522966","volume":"196","author":"H Nose","year":"2007","unstructured":"Nose H, Kubota R, Seth NP, Goon PK, Tanaka Y, Izumo S, Usuku K, Ohara Y, Wucherpfennig KW, Bangham CR, Osame M, Saito M (2007) Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide. J Infect Dis 196:1761\u20131772","journal-title":"J Infect Dis"},{"key":"192_CR89","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1086\/503874","volume":"193","author":"U Oh","year":"2006","unstructured":"Oh U, Grant C, Griffith C, Fugo K, Takenouchi N, Jacobson S (2006) Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 Infection. J Infect Dis 193:1557\u20131566","journal-title":"J Infect Dis"},{"key":"192_CR90","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/archneur.63.11.1560","volume":"63","author":"S Olindo","year":"2006","unstructured":"Olindo S, Cabre P, Lezin A, Merle H, Saint-Vil M, Signate A, Bonnan M, Chalon A, Magnani L, Cesaire R, Smadja D (2006) Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study. Arch Neurol 63:1560\u20131566","journal-title":"Arch Neurol"},{"key":"192_CR91","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1182\/blood-2011-04-349910","volume":"118","author":"S Olindo","year":"2011","unstructured":"Olindo S, Belrose G, Gillet N, Rodriguez S, Boxus M, Verlaeten O, Asquith B, Bangham C, Signate A, Smadja D, Lezin A, Cesaire R, Willems L (2011) Safety of long-term treatment of HAM\/TSP patients with valproic acid. Blood 118:6306\u20136309","journal-title":"Blood"},{"key":"192_CR92","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet 1:1031\u20131032","journal-title":"Lancet"},{"key":"192_CR93","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ana.410280110","volume":"28","author":"M Osame","year":"1990","unstructured":"Osame M, Janssen R, Kubota H, Nishitani H, Igata A, Nagataki S, Mori M, Goto I, Shimabukuro H, Khabbaz R et al (1990) Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Ann Neurol 28:50\u201356","journal-title":"Ann Neurol"},{"key":"192_CR94","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77:7415\u20137419","journal-title":"Proc Natl Acad Sci U S A"},{"key":"192_CR95","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24:6058\u20136068","journal-title":"Oncogene"},{"key":"192_CR96","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.4049\/jimmunol.0903226","volume":"184","author":"S Rahman","year":"2010","unstructured":"Rahman S, Manuel SL, Khan ZK, Wigdahl B, Acheampong E, Tangy F, Jain P (2010) Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice. J Immunol 184:5553\u20135561","journal-title":"J Immunol"},{"key":"192_CR97","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4049\/jimmunol.1002570","volume":"186","author":"S Rahman","year":"2011","unstructured":"Rahman S, Khan ZK, Wigdahl B, Jennings SR, Tangy F, Jain P (2011) Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection. J Immunol 186:390\u2013402","journal-title":"J Immunol"},{"key":"192_CR98","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1086\/429410","volume":"191","author":"DF Roucoux","year":"2005","unstructured":"Roucoux DF, Wang B, Smith D, Nass CC, Smith J, Hutching ST, Newman B, Lee TH, Chafets DM, Murphy EL (2005) A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J Infect Dis 191:1490\u20131497","journal-title":"J Infect Dis"},{"key":"192_CR99","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1086\/423942","volume":"190","author":"AH Sabouri","year":"2004","unstructured":"Sabouri AH, Saito M, Lloyd AL, Vine AM, Witkover AW, Furukawa Y, Izumo S, Arimura K, Marshall SE, Usuku K, Bangham CR, Osame M (2004) Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis. J Infect Dis 190:1279\u20131285","journal-title":"J Infect Dis"},{"key":"192_CR100","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1099\/vir.0.80509-0","volume":"86","author":"AH Sabouri","year":"2005","unstructured":"Sabouri AH, Saito M, Usuku K, Bajestan SN, Mahmoudi M, Forughipour M, Sabouri Z, Abbaspour Z, Goharjoo ME, Khayami E, Hasani A, Izumo S, Arimura K, Farid R, Osame M (2005) Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J Gen Virol 86:773\u2013781","journal-title":"J Gen Virol"},{"key":"192_CR101","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2008-02-140335","volume":"112","author":"AH Sabouri","year":"2008","unstructured":"Sabouri AH, Usuku K, Hayashi D, Izumo S, Ohara Y, Osame M, Saito M (2008) Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease. Blood 112:2411\u20132420","journal-title":"Blood"},{"key":"192_CR102","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/JVI.75.2.1065-1071.2001","volume":"75","author":"M Saito","year":"2001","unstructured":"Saito M, Taylor GP, Saito A, Furukawa Y, Usuku K, Weber JN, Osame M, Bangham CR (2001) In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes. J Virol 75:1065\u20131071","journal-title":"J Virol"},{"key":"192_CR103","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1086\/344315","volume":"186","author":"M Saito","year":"2002","unstructured":"Saito M, Higuchi I, Saito A, Izumo S, Usuku K, Bangham CR, Osame M (2002) Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. J Infect Dis 186:1231\u20131241","journal-title":"J Infect Dis"},{"key":"192_CR104","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood-2002-09-2855","volume":"102","author":"M Saito","year":"2003","unstructured":"Saito M, Braud VM, Goon P, Hanon E, Taylor GP, Saito A, Eiraku N, Tanaka Y, Usuku K, Weber JN, Osame M, Bangham CR (2003) Low frequency of CD94\/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis, but not in asymptomatic carriers. Blood 102:577\u2013584","journal-title":"Blood"},{"key":"192_CR105","first-page":"123637","volume":"2012","author":"M Saito","year":"2012","unstructured":"Saito M, Jain P, Tsukasaki K, Bangham CR (2012) HTLV-1 infection and its associated diseases. Leuk Res Treat 2012:123637","journal-title":"Leuk Res Treat"},{"key":"192_CR106","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","volume":"212","author":"S Sakaguchi","year":"2006","unstructured":"Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212:8\u201327","journal-title":"Immunol Rev"},{"key":"192_CR107","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/CMR.14.4.778-809.2001","volume":"14","author":"CE Samuel","year":"2001","unstructured":"Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14:778\u2013809, table of contents","journal-title":"Clin Microbiol Rev"},{"key":"192_CR108","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1002\/j.1460-2075.1987.tb02660.x","volume":"6","author":"H Shida","year":"1987","unstructured":"Shida H, Tochikura T, Sato T, Konno T, Hirayoshi K, Seki M, Ito Y, Hatanaka M, Hinuma Y, Sugimoto M et al (1987) Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection. EMBO J 6:3379\u20133384","journal-title":"EMBO J"},{"key":"192_CR109","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-510X(97)00074-9","volume":"151","author":"S Shirabe","year":"1997","unstructured":"Shirabe S, Nakamura T, Tsujino A, Nishiura Y, Furuya T, Goto H, Suenaga A, Nakane S, Yoshimura T, Nagataki S (1997) Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy. J Neurol Sci 151:97\u2013101","journal-title":"J Neurol Sci"},{"key":"192_CR110","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0140-6736(87)91362-6","volume":"2","author":"M Sugimoto","year":"1987","unstructured":"Sugimoto M, Nakashima H, Watanabe S, Uyama E, Tanaka F, Ando M, Araki S, Kawasaki S (1987) T-lymphocyte alveolitis in HTLV-I-associated myelopathy. Lancet 2:1220","journal-title":"Lancet"},{"key":"192_CR111","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1164\/ajrccm\/139.6.1329","volume":"139","author":"M Sugimoto","year":"1989","unstructured":"Sugimoto M, Nakashima H, Matsumoto M, Uyama E, Ando M, Araki S (1989) Pulmonary involvement in patients with HTLV-I-associated myelopathy: increased soluble IL-2 receptors in bronchoalveolar lavage fluid. Am Rev Respir Dis 139:1329\u20131335","journal-title":"Am Rev Respir Dis"},{"key":"192_CR112","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ijc.2910450206","volume":"45","author":"K Tajima","year":"1990","unstructured":"Tajima K (1990) The 4th nation-wide study of adult T-cell leukemia\/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer 45:237\u2013243","journal-title":"Int J Cancer"},{"key":"192_CR113","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/13550280390173418","volume":"9","author":"N Takenouchi","year":"2003","unstructured":"Takenouchi N, Yamano Y, Usuku K, Osame M, Izumo S (2003) Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis. J Neurovirol 9:29\u201335","journal-title":"J Neurovirol"},{"key":"192_CR114","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood.V82.12.3664.3664","volume":"82","author":"Y Tanaka","year":"1993","unstructured":"Tanaka Y, Ishii K, Sawada T, Ohtsuki Y, Hoshino H, Yanagihara R, Miyoshi I (1993) Prophylaxis against a Melanesian variant of human T-lymphotropic virus type I (HTLV-I) in rabbits using HTLV-I immune globulin from asymptomatically infected Japanese carriers. Blood 82:3664\u20133667","journal-title":"Blood"},{"key":"192_CR115","doi-asserted-by":"crossref","first-page":"6323","DOI":"10.1128\/jvi.68.10.6323-6331.1994","volume":"68","author":"Y Tanaka","year":"1994","unstructured":"Tanaka Y, Tanaka R, Terada E, Koyanagi Y, Miyano-Kurosaki N, Yamamoto N, Baba E, Nakamura M, Shida H (1994) Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. J Virol 68:6323\u20136331","journal-title":"J Virol"},{"key":"192_CR116","doi-asserted-by":"crossref","first-page":"e1002480","DOI":"10.1371\/journal.ppat.1002480","volume":"8","author":"S Tattermusch","year":"2012","unstructured":"Tattermusch S, Skinner JA, Chaussabel D, Banchereau J, Berry MP, McNab FW, O'Garra A, Taylor GP, Bangham CR (2012) Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy. PLoS Pathog 8:e1002480","journal-title":"PLoS Pathog"},{"key":"192_CR117","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1742-4690-3-63","volume":"3","author":"GP Taylor","year":"2006","unstructured":"Taylor GP, Goon P, Furukawa Y, Green H, Barfield A, Mosley A, Nose H, Babiker A, Rudge P, Usuku K, Osame M, Bangham CR, Weber JN (2006) Zidovudine plus lamivudine in human T-lymphotropic virus type-I-associated myelopathy: a randomised trial. Retrovirology 3:63","journal-title":"Retrovirology"},{"key":"192_CR118","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(94)90630-0","volume":"344","author":"K Terada","year":"1994","unstructured":"Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, Yamashita I, Iwata K, Tsuji Y, Nagataki S et al (1994) Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren's syndrome. Lancet 344:1116\u20131119","journal-title":"Lancet"},{"key":"192_CR119","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1182\/blood-2007-10-118539","volume":"111","author":"F Toulza","year":"2008","unstructured":"Toulza F, Heaps A, Tanaka Y, Taylor GP, Bangham CR (2008) High frequency of CD4+ FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood 111:5047\u20135053","journal-title":"Blood"},{"key":"192_CR120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4049\/jimmunol.0903846","volume":"185","author":"F Toulza","year":"2010","unstructured":"Toulza F, Nosaka K, Tanaka Y, Schioppa T, Balkwill F, Taylor GP, Bangham CR (2010) Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. J Immunol 185:183\u2013189","journal-title":"J Immunol"},{"key":"192_CR121","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev.immunol.15.1.15","volume":"15","author":"T Uchiyama","year":"1997","unstructured":"Uchiyama T (1997) Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 15:15\u201337","journal-title":"Annu Rev Immunol"},{"key":"192_CR122","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H (1977) Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481\u2013492","journal-title":"Blood"},{"key":"192_CR123","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","volume":"7","author":"K Verdonck","year":"2007","unstructured":"Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, Gotuzzo E (2007) Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7:266\u2013281","journal-title":"Lancet Infect Dis"},{"key":"192_CR124","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1086\/342953","volume":"186","author":"AM Vine","year":"2002","unstructured":"Vine AM, Witkover AD, Lloyd AL, Jeffery KJ, Siddiqui A, Marshall SE, Bunce M, Eiraku N, Izumo S, Usuku K, Osame M, Bangham CR (2002) Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Infect Dis 186:932\u2013939","journal-title":"J Infect Dis"},{"key":"192_CR125","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.4049\/jimmunol.173.8.5121","volume":"173","author":"AM Vine","year":"2004","unstructured":"Vine AM, Heaps AG, Kaftantzi L, Mosley A, Asquith B, Witkover A, Thompson G, Saito M, Goon PK, Carr L, Martinez-Murillo F, Taylor GP, Bangham CR (2004) The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1. J Immunol 173:5121\u20135129","journal-title":"J Immunol"},{"key":"192_CR126","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1172\/JCI23913","volume":"115","author":"Y Yamano","year":"2005","unstructured":"Yamano Y, Takenouchi N, Li HC, Tomaru U, Yao K, Grant CW, Maric DA, Jacobson S (2005) Virus-induced dysfunction of CD4+ CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest 115:1361\u20131368","journal-title":"J Clin Invest"},{"key":"192_CR127","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1073\/pnas.81.8.2534","volume":"81","author":"M Yoshida","year":"1984","unstructured":"Yoshida M, Seiki M, Yamaguchi K, Takatsuki K (1984) Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A 81:2534\u20132537","journal-title":"Proc Natl Acad Sci U S A"},{"key":"192_CR128","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/jnnp.56.9.1004","volume":"56","author":"A Yoshioka","year":"1993","unstructured":"Yoshioka A, Hirose G, Ueda Y, Nishimura Y, Sakai K (1993) Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM). J Neurol Neurosurg Psychiatry 56:1004\u20131007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"192_CR129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-5728(91)90056-D","volume":"33","author":"F Yu","year":"1991","unstructured":"Yu F, Itoyama Y, Fujihara K, Goto I (1991) Natural killer (NK) cells in HTLV-I-associated myelopathy\/tropical spastic paraparesis-decrease in NK cell subset populations and activity in HTLV-I seropositive individuals. J Neuroimmunol 33:121\u2013128","journal-title":"J Neuroimmunol"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-013-0192-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-013-0192-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-013-0192-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-013-0192-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:32:33Z","timestamp":1684866753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-013-0192-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,14]]},"references-count":129,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["192"],"URL":"https:\/\/doi.org\/10.1007\/s13365-013-0192-8","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,14]]},"assertion":[{"value":"19 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}